Shineco, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Jennifer Zhan
- Full Time Employees
- 119
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- North Tower, Zhengda Center Beijing People's Republic of China 100020
- IPO Date
- Sep 28, 2016
- CIK
- 0001300734
- Website
- biosisi.com
- Similar Companies
- Business
- Shineco, Inc. Shineco, Inc. (NASDAQ: SISI), founded in 2005 and headquartered in Beijing, China, operates as a holding company focused on developing and commercializing induced pluripotent stem cell (iPSC) technology platforms and extracellular vesicle-derived products; through subsidiaries such as Changzhou Biowin Pharmaceutical Co., Ltd. and Xi'an Dong'ao Health Management Co., Ltd., it engages in the production, distribution, and sale of plant-based nutritional products, traditional Chinese medicine (TCM) items including herbal medicines and supplements targeting chronic, geriatric, and maternal health needs, point-of-care testing (POCT) diagnostics encompassing 15 series and 45 products across domestic and international markets with certifications like EU CE and filings in Australia, Spain, Thailand, and Japan, as well as medical devices and stool sample collection solutions; the company primarily serves health-conscious consumers, aging populations, and clinical markets in China and Southeast Asia with expanding global reach via platforms like German Amazon. Shineco, Inc. conducts operations in China with recent international extensions into Singapore and Southeast Asia through over 3,000 distribution agents. In recent developments, it acquired a 75% stake in FuWang Company for approximately $8.8 million in cash and shares in March 2025 to bolster its medical device business, secured an $8.7 million technology services contract in September 2025 with Xinke Future Biotechnology for microalgae-derived extracellular vesicles research and development through December 2026 including initial $560,000 payment and mass production milestones, and formed a strategic alliance with Singapore's BICC establishing a joint laboratory, technology exchange, and integrated distribution channels for stem cell therapy centers and standardized clinical services.
Shineco (NASDAQ:SISI) Shares Up 2.9% – Here’s Why
Financial Comparison: NewAmsterdam Pharma (NASDAQ:NAMS) and Shineco (NASDAQ:SISI)
Shineco (NASDAQ:SISI) Shares Down 6.8% – Here’s Why
Shineco (NASDAQ:SISI) Shares Up 51.6% – Here’s Why
Shineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual Engines
Shineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across Industries
Shineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term Growth
Shineco Unveils World's First On-Chain Cell Asset Tokenization Platform; Strategic Acquisition Expands Global Blockchain-Biotech Network
Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology
Shineco, Inc. to Effect 50:1 Reverse Stock Split
Shineco Announces Acquisition of Medical Device Company
Future FinTech Announces the Appointment of Hu Li as the New CEO
Shineco Announces Closing of $2 Million Underwritten Public Offering
Why Is Shineco (SISI) Stock Down 54% Today?
Shineco Announces Pricing of $2 Million Underwritten Public Offering
Shineco Announces Proposed Underwritten Public Offering
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million
Shineco Enters into a Letter of Intent with Meitong Technology to Address China's Aging Population
Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products